Native Mass Spectrometry Quantitation of α2-3-Linked N-Acetylneuraminic Acid Content of Prostate-Specific Antigen: An Accurate Liquid Biopsy for Clinically Significant Prostate Cancer | Analytical Chemistry
MAJOR LEAGUE BASEBALL AND PROSTATE CANCER FOUNDATION PARTNER ON 26TH ANNUAL HOME RUN CHALLENGE AND TOUR
InfoCancer - ARCAGY - GINECO - Localisations - Cancers masculins - Cancer de la prostate - Symptômes & diagnostic - Le bilan initial
Using PSMA imaging for prognostication in localized and advanced prostate cancer | Nature Reviews Urology
Prostate Cancer Treatment (PDQ®) - NCI
A 59-year-old male with newly diagnosed prostate cancer (GS: 4+4, ISUP... | Download Scientific Diagram
Cancer de la prostate : l'autotest de nouveau autorisé - AlloDocteurs
IJMS | Free Full-Text | Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
Cancers | Free Full-Text | Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges
Beyond PSA: The Next Generation of Prostate Cancer Biomarkers | Science Translational Medicine
There is current over-treatment of prostate cancer in France - Inserm Newsroom
Frontiers | A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016 in: Journal of the National Comprehensive Cancer Network Volume 14 Issue 5 (2016)
Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management | Clinical Proteomics | Full Text
Screening and prostate cancer | PPT
A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients | British Journal of Cancer
Taux de PSA et cancer de la prostate, dépistage
Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml | Prostate Cancer and Prostatic Diseases
Overall survival and prostate cancer specific-survival according to... | Download Scientific Diagram
Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men | Prostate Cancer and Prostatic Diseases
Frontiers | Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
Le taux du PSA et son incidence sur le cancer de la prostate | Test PSA
Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management | Clinical Proteomics | Full Text
